Evofem Biosciences (EVFM) Short Interest Ratio & Short Volume $0.0096 +0.00 (+2.13%) As of 06/5/2025 03:52 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Evofem Biosciences Short Interest DataEvofem Biosciences (EVFM) has a short interest of 400 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 463,506 shares to cover all short positions.Current Short Interest400 sharesPrevious Short Interest400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$3.64Short Interest Ratio0.0 Days to CoverLast Record DateMay 15, 2025Outstanding Shares118,656,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume65,143 sharesAverage Trading Volume463,506 sharesToday's Volume Vs. Average14% Short Selling Evofem Biosciences? Sign up to receive the latest short interest report for Evofem Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEVFM Short Interest Over TimeEVFM Days to Cover Over TimeEVFM Percentage of Float Shorted Over Time Evofem Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2025400 shares $3.64 No ChangeN/A0 $0.01 4/30/2025400 shares $3.52 -98.3%N/A0 $0.01 4/15/202524,000 shares $206.40 +2.6%N/A0 $0.01 3/14/202565,900 shares $527.20 -29.2%N/A0.1 $0.01 2/28/202593,100 shares $782.04 +946.1%N/A0 $0.01 2/14/20258,900 shares $84.55 -40.7%N/A0 $0.01 1/31/202515,000 shares $147.00 -61.1%N/A0 $0.01 1/15/202538,600 shares $366.70 -48.5%N/A0 $0.01 7/31/20228,680,000 shares $6.34 million -21.0%22.9%0.3 $0.73 7/15/202210,990,000 shares $9.65 million -38.3%29.0%0.4 $0.88 Get the Latest News and Ratings for EVFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter. 6/30/202217,820,000 shares $20.14 million +744.6%51.9%0.7 $1.13 6/15/20222,110,000 shares $623,083.00 +6.0%17.1%0.6 $0.30 5/31/20221,990,000 shares $716,400.00 +64.5%15.9%1.2 $0.36 5/15/20221,210,000 shares $1.38 million +1.7%9.7%1.8 $1.14 4/30/20221,190,000 shares $3.14 million -93.3%N/A5 $2.64 4/15/202217,790,000 shares $4.02 million +2.8%N/A6.5 $0.23 3/31/202217,310,000 shares $5.89 million -8.2%N/A4.6 $0.34 3/15/202218,850,000 shares $6.97 million -8.0%N/A5 $0.37 2/28/202220,480,000 shares $9.90 million -20.1%N/A5.1 $0.48 2/15/202225,640,000 shares $11.00 million -1.0%N/A6.5 $0.43 1/31/202225,910,000 shares $11.71 million -3.3%N/A6 $0.45 1/15/202226,780,000 shares $10.98 million +5.4%N/A6.1 $0.41 12/31/202125,420,000 shares $9.56 million +3.4%N/A8 $0.38 12/15/202124,590,000 shares $9.34 million +0.4%16.1%7.7 $0.38 11/30/202124,490,000 shares $10.87 million -8.2%N/A9 $0.44 11/15/202126,670,000 shares $17.74 million -1.5%N/A8.4 $0.67 10/29/202127,080,000 shares $18.62 million -1.7%N/A8.4 $0.69 10/15/202127,550,000 shares $19.09 million -0.7%18.1%8 $0.69 9/30/202127,740,000 shares $20.50 million -2.3%18.2%7.4 $0.74 9/15/202128,390,000 shares $22.43 million +5.6%18.6%6.5 $0.79 8/31/202126,880,000 shares $23.84 million -3.4%17.6%3.5 $0.89 8/13/202127,820,000 shares $19.78 million -1.5%18.2%2.8 $0.71 7/30/202128,240,000 shares $24.29 million +0.6%18.8%2.3 $0.86 7/15/202128,070,000 shares $25.82 million -2.3%18.9%2.3 $0.92 6/30/202128,720,000 shares $32.45 million +15.3%19.3%2.4 $1.13 6/15/202124,900,000 shares $30.13 million +130.1%16.7%2.1 $1.21 5/28/202110,820,000 shares $9.31 million -5.5%N/A1.2 $0.86 5/14/202111,450,000 shares $13.97 million -5.2%N/A1.6 $1.22 4/30/202112,080,000 shares $17.64 million +0.1%N/A2.5 $1.46 4/15/202112,070,000 shares $19.79 million +30.8%N/A0 $1.64White House to reset Social Security? (Ad)Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. And it could have a major impact on how you collect Social Security - Click here to understand what' 3/31/20219,230,000 shares $15.97 million +3.4%N/A1.9 $1.73 3/15/20218,930,000 shares $25.54 million -5.1%N/A2.1 $2.86 2/26/20219,410,000 shares $37.73 million -0.3%N/A2.3 $4.01 2/12/20219,440,000 shares $37.76 million -0.7%N/A2.5 $4.00 1/29/20219,510,000 shares $25.20 million -8.6%N/A3.2 $2.65 1/15/202110,400,000 shares $27.66 million -11.0%N/A4.2 $2.66 12/31/202011,690,000 shares $28.41 million +22.2%N/A5 $2.43 12/15/20209,570,000 shares $20.38 million +32.0%N/A4 $2.13 11/30/20207,250,000 shares $16.60 million -7.3%N/A2.2 $2.29 11/15/20207,820,000 shares $17.13 million +5.0%N/A2 $2.19 10/30/20207,450,000 shares $18.55 million -15.1%N/A1.8 $2.49 10/15/20208,770,000 shares $24.21 million -25.7%N/A1.9 $2.76 9/30/202011,800,000 shares $27.85 million -9.7%N/A2.6 $2.36 9/15/202013,060,000 shares $28.47 million +140.1%N/A2.8 $2.18 8/31/20205,440,000 shares $18.06 million +48.2%N/A1.3 $3.32 8/14/20203,670,000 shares $11.49 million -3.2%N/A0.9 $3.13 7/31/20203,790,000 shares $11.33 million +10.2%N/A1 $2.99 7/15/20203,440,000 shares $9.91 million +39.3%N/A1 $2.88 6/30/20202,470,000 shares $6.99 million +32.1%N/A0.8 $2.83 6/15/20201,870,000 shares $5.52 million -51.2%N/A0.8 $2.95 EVFM Short Interest - Frequently Asked Questions What is Evofem Biosciences' current short interest? Short interest is the volume of Evofem Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 400 shares of EVFM short. Learn More on Evofem Biosciences' current short interest. How does Evofem Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Evofem Biosciences: Dermata Therapeutics, Inc. (2.20%), Titan Pharmaceuticals, Inc. (1.27%), Alaunos Therapeutics, Inc. (4.39%), Galecto, Inc. (4.86%), Matinas Biopharma Holdings, Inc. (1.94%), 60 Degrees Pharmaceuticals, Inc. (2.36%), InMed Pharmaceuticals Inc. (12.93%), RedHill Biopharma Ltd. (5.19%), Clearmind Medicine Inc. (5.50%), Tharimmune, Inc. (2.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Evofem Biosciences stock? Short selling EVFM is an investing strategy that aims to generate trading profit from Evofem Biosciences as its price is falling. EVFM shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evofem Biosciences? A short squeeze for Evofem Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EVFM, which in turn drives the price of the stock up even further. How often is Evofem Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVFM, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies Dermata Therapeutics Short Interest Titan Pharmaceuticals Short Interest Alaunos Therapeutics Short Interest Galecto Short Interest Matinas Biopharma Short Interest 60 Degrees Pharmaceuticals Short Interest InMed Pharmaceuticals Short Interest RedHill Biopharma Short Interest Clearmind Medicine Short Interest Tharimmune Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EVFM) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredHow to target 627% gains from Trump’s tweetsPresident Trump is shaking up the market with his tweets and Truth Social posts... But while this chaos has...Monument Traders Alliance | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredTrump plotting new lockdown?It's listed inside the White House's own documents: Federal Register notice 90 FR 4544 to be exact. And wh...Porter & Company | SponsoredWhy hasn't Elon tweeted about this?Behind the scenes, there's an entirely different Tesla story brewing… . It's about a quiet stream of income...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.